{"database": "openregs", "table": "roll_call_votes", "rows": [[119, "senate", 2, 103, "2026-04-23", "On the Amendment S.Amdt. 5336 to S.Con.Res. 33 (No short title on file)", "", "Wyden Amdt. No. 5336 -- To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.", "Amendment Rejected", null, null, null, 48, 50, 0, 2, "https://www.senate.gov/legislative/LIS/roll_call_votes/vote1192/vote_119_2_00103.xml"]], "columns": ["congress", "chamber", "session", "roll_call_number", "date", "question", "vote_type", "description", "result", "bill_id", "legislation_type", "legislation_number", "yea_count", "nay_count", "present_count", "not_voting_count", "source_url"], "primary_keys": ["congress", "chamber", "session", "roll_call_number"], "primary_key_values": ["119", "senate", "2", "103"], "units": {}, "query_ms": 0.41637709364295006, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}